| Sanara MedTech Inc. (SMTI) Q1 2025 Earnings Call Transcript |
Sanara MedTech Inc. (NASDAQ:SMTI ) Q1 2025 Earnings Conference Call May 14, 2025 8:00 AM ET Company Participants Ron Nixon - Executive Chairman, Chief Executive Officer Seth Yon - President, Chief Commercial Officer Sam Muppalla - President, Chief Executive Officer of Tissue Health Plus Elizabeth Taylor - Chief Financial Officer Conference Call Participants Matt Park - Cantor Fitzgerald Operator Welcome to the Sanara MedTech First Quarter of 2025 Earnings Conference Call. Please note that this conference call is being recorded and a replay will be available on the Investor Relations page of the company's website shortly. |
seekingalpha.com |
2025-05-14 15:55:29 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. (SMTI) Reports Q1 Loss, Tops Revenue Estimates |
Sanara MedTech Inc. (SMTI) came out with a quarterly loss of $0.41 per share versus the Zacks Consensus Estimate of a loss of $0.31. This compares to loss of $0.21 per share a year ago. |
zacks.com |
2025-05-14 13:51:05 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited) |
Q1 Net Revenue Increased 26% Year-Over-Year FORT WORTH, TX, May 14, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today reported its financial results for the first quarter ended March 31, 2025. First Quarter 2025 Financial Summary ● Net revenue increased 26% to $23.4 million, compared to $18.5 million in the first quarter of 2024. |
globenewswire.com |
2025-05-14 11:00:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025 |
FORT WORTH, TX, April 23, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced it will report its first quarter 2025 financial results on Wednesday, May 14, 2025 before the U.S. financial markets open. |
globenewswire.com |
2025-04-23 12:00:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025 |
FORT WORTH, TX, April 10, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that management will present at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub, which is being held at the Paris Hotel & Casino in Las Vegas, NV from April 22 – 25, 2025. Management will deliver a presentation to investors on Wednesday, April 23 at approximately 3:30 p.m. Pacific Time. |
globenewswire.com |
2025-04-10 20:00:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech (SMTI) Stock Jumps 8.1%: Will It Continue to Soar? |
Sanara MedTech (SMTI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road. |
zacks.com |
2025-04-10 16:40:51 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. (SMTI) Q4 2024 Earnings Call Transcript |
Sanara MedTech Inc. (NASDAQ:SMTI ) Q4 2024 Earnings Conference Call March 25, 2025 8:00 AM ET Company Participants Ron Nixon - Executive Chairman and Chief Executive Officer Seth Yon - President, Commercial Sam Muppalla - Tissue Health Plus Tyler Palmer - Chief Corporate Development and Strategy Officer Elizabeth Taylor - Chief Financial Officer Conference Call Participants Ross Osborn - Cantor Fitzgerald Operator Good day, and welcome to the Sanara MedTech Fourth Quarter and Full-Year 2024 Earnings Conference Call. Please not that this conference call is being recorded and a replay will be available on the investor relations page of the company's website shortly. |
seekingalpha.com |
2025-03-25 11:15:19 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited) |
Q4 Net Revenue Increased 49% Year-Over-Year; 2024 Net Revenue Increased 33% Year-Over-Year FORT WORTH, TX, March 25, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today reported its financial results for the fourth quarter and full year ended December 31, 2024. Fourth Quarter 2024 Financial Summary ● Net revenue increased 49% to $26.3 million, compared to $17.7 million in the fourth quarter of 2023. |
globenewswire.com |
2025-03-25 09:00:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 |
FORT WORTH, TX, March 11, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . (“Sanara,” or the “Company”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced it will report its fourth quarter and full year 2024 financial results on Tuesday, March 25, 2025 before the U.S. financial markets open. |
globenewswire.com |
2025-03-11 18:05:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech: A Promising Growth Story At An Attractive Valuation |
Shares have risen nearly 15% since the company posted preliminary Q4 results, which showed revenue up by 45-48% year over year. While growth was boosted by one-off demand for its BIASURGE product, underlying growth was still strong at 37%. There remains a long runway for growth for its surgical products, with the potential for this to be augmented by other growth drivers, including inorganic opportunities. |
seekingalpha.com |
2025-01-30 14:28:05 |
Czytaj oryginał (ang.) |
| Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc. |
SHANNON, Ireland, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Irish medical device company Biomimetic Innovations Limited, an affiliate of PBC Biomed, today announced the execution of an exclusive license and distribution agreement with Sanara MedTech Inc (“Sanara”) (Nasdaq:SMTI). In tandem, Sanara agreed to make a minority investment in cash for equity in BMI. |
globenewswire.com |
2025-01-24 09:00:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd |
OsStic ® and related technologies represent differentiated solutions that address an estimated 100,000+ procedures in the U.S. annually ( 1) ; arrangement leverages Sanara's existing call points and commercial infrastructure, and complements Sanara's existing surgical portfolio |
globenewswire.com |
2025-01-21 18:10:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments |
Elizabeth Taylor Appointed Chief Financial Officer; Michael McNeil Appointed Chief Accounting Officer and Chief Administrative Officer |
globenewswire.com |
2025-01-21 18:08:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024 |
Fourth Quarter Net Revenue Expected to Increase 45% to 48% Year-Over-Year; Full Year Net Revenue Expected to Increase 32% to 33% Year-Over-Year |
globenewswire.com |
2025-01-21 18:05:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th |
FORT WORTH, TX, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that Ron Nixon, the Company's Chairman and Chief Executive Officer, will present at the Piper Sandler 36th Annual Healthcare Conference, which is being held at The Lotte New York Palace in New York, NY from December 3 – 5, 2024. Mr. Nixon will deliver a presentation to investors on Wednesday, December 4 at approximately 11:50 a.m. Eastern Time. |
globenewswire.com |
2024-11-25 18:05:00 |
Czytaj oryginał (ang.) |
| All You Need to Know About Sanara MedTech (SMTI) Rating Upgrade to Buy |
Sanara MedTech (SMTI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term. |
zacks.com |
2024-11-19 15:01:08 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. (SMTI) Q3 2024 Earnings Call Transcript |
Sanara MedTech Inc. (NASDAQ:SMTI ) Q3 2024 Earnings Conference Call November 13, 2024 9:00 AM ET Company Participants Ronald Nixon - Executive Chairman and CEO Seth Yon - President of Commercial Michael McNeil - Chief Financial Officer Sam Muppalla - Tissue Health Plus Conference Call Participants Ross Osborn - Cantor Fitzgerald Ian Cassel - MicroCapClub Chris Plahm - Tall Pines Capital John Siedhoff - Twin Oaks Equity Operator Good morning, and welcome to the Sanara MedTech Third Quarter 2024 Earnings Conference Call. The company issued its earnings release yesterday and will post today's supplemental deck on the Investor Relations page on the company's website. |
seekingalpha.com |
2024-11-13 16:47:06 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Reports Third Quarter 2024 Results |
FORT WORTH, TX, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today reported its strategic, operational and financial results for the quarter ended September 30, 2024. |
globenewswire.com |
2024-11-12 18:15:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates |
FORT WORTH, TX, Oct. 31, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended September 30, 2024. Sanara will issue its earnings release on Tuesday, November 12, 2024, and will host a conference call on Wednesday, November 13, 2024, at 9:00 a.m. |
globenewswire.com |
2024-10-31 11:15:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces Changes to Its Board of Directors |
FORT WORTH, TX, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. -- Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara” or the “Company”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets announced today changes to its Board of Directors (“Board”). After a long tenure of service with the predecessor company and Sanara, Mr. James “Jim” Stuckert has resigned from his position as a director, and Mr. Keith Myers has been appointed to serve as a director on the Board in order to fill the vacancy resulting from Mr. Stuckert's resignation. Mr. Stuckert will continue to serve the Board as Director Emeritus. |
globenewswire.com |
2024-10-07 13:15:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc (SMTI) Trading 3.79% Higher on Oct 2 |
Shares of Sanara MedTech Inc (SMTI, Financial) surged 3.79% in mid-day trading on Oct 2. The stock reached an intraday high of $30.10, up from its previous close of $29.00. |
gurufocus.com |
2024-10-02 16:04:47 |
Czytaj oryginał (ang.) |
| Sanara Stock Gains From New US Distribution Deal With ChemoMouthPiece |
SMTI, along with InfuSystem, inked a U.S. distribution agreement with ChemoMouthpiece. Under the agreement, ChemoMouthpiece's oral cryotherapy device will be distributed in cancer centers. |
zacks.com |
2024-09-12 13:46:28 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC |
FORT WORTH, TX, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on improving clinical outcomes and reducing healthcare expenditures in the surgical, chronic wound and skincare markets, and InfuSystem, Inc. (“InfuSystem”), the operational subsidiary of Sanara's joint venture partner InfuSystem Holdings, Inc., announced today the execution of an exclusive United States distribution agreement with, and minority investment in, ChemoMouthpiece, LLC (“ChemoMouthpiece”). |
globenewswire.com |
2024-09-11 10:30:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces Second Quarter 2024 Results |
FORT WORTH, TX, Aug. 12, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today its strategic, operational and financial results for the quarter ended June 30, 2024. |
globenewswire.com |
2024-08-12 20:15:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates |
FORT WORTH, TX, July 30, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended June 30, 2024. |
globenewswire.com |
2024-07-30 13:15:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript |
Sanara MedTech Inc. (NASDAQ:SMTI ) Q1 2024 Earnings Conference Call May 14, 2024 9:00 AM ET Company Participants Callon Nichols - Director of IR Ron Nixon - Executive Chairman Mike McNeil - CFO Seth Yon - President, Commercial Conference Call Participants Ian Cassel - IFCM Operator Greetings, welcome to the Sanara MedTech Inc. First Quarter Results and Business Update Conference Call. At this time all participants are in a listen-only mode. |
seekingalpha.com |
2024-05-14 19:00:07 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces First Quarter 2024 Results |
FORT WORTH, TX, May 13, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today its strategic, operational and financial results for the quarter ended March 31, 2024. |
globenewswire.com |
2024-05-13 13:15:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates |
FORT WORTH, TX, April 29, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter ended March 31, 2024. |
globenewswire.com |
2024-04-29 13:15:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces $55 Million Debt Facility |
FORT WORTH, TX, April 18, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today that it has entered into a $55.0 million non-dilutive term loan agreement with CRG Servicing LLC, an affiliate of CRG LP (“CRG”), a healthcare focused investment fund, to support the Company's growth initiatives in 2024 and 2025. |
globenewswire.com |
2024-04-18 13:15:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer |
FORT WORTH, TX, April 05, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today the appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer. |
globenewswire.com |
2024-04-05 13:00:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results |
FORT WORTH, TX, March 25, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today its strategic, operational and financial results for the quarter and full year ended December 31, 2023. |
globenewswire.com |
2024-03-25 18:05:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release and Conference Call Dates |
FORT WORTH, TX, March 13, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, today announced details for the release of its results for the quarter and year ended December 31, 2023. |
globenewswire.com |
2024-03-13 11:15:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces Unaudited Preliminary Results for the Fourth Quarter and Full Year 2023 |
FORT WORTH, TX, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets, announced today certain unaudited preliminary results for the fourth quarter and full-year 2023. |
globenewswire.com |
2024-02-22 11:15:00 |
Czytaj oryginał (ang.) |
| Sanara MedTech Inc. Announces Exclusive License Agreement for Patented Collagen Peptides |
FORT WORTH, TX, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Sanara MedTech Inc . Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), announced today that is has signed an exclusive license agreement with Tufts University (“Tufts”) to develop and commercialize patented technology covering 18 unique collagen peptides. |
globenewswire.com |
2024-01-03 11:15:00 |
Czytaj oryginał (ang.) |